Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

70.41
Delayed Data
As of 1:27pm ET
 +0.30 / +0.43%
Today’s Change
37.35
Today|||52-Week Range
75.98
+81.94%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close70.11
Today’s open70.47
Day’s range70.21 - 71.51
Volume229,191
Average volume (3 months)888,603
Market cap$6.2B
Data as of 1:27pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)-55.24%
Earnings growth (this year)-1.90%
Earnings growth (next 5 years)-14.47%
Revenue growth (last year)-24.12%
P/E ratioNM
Price/Sales223.72
Price/Book19.35

Competitors

 Today’s
change
Today’s
% change
JUNOJuno Therapeutics In...+1.69+3.69%
BLUEbluebird bio Inc-8.90-4.66%
TECHBio-Techne Corp-0.08-0.06%
EXASExact Sciences Corp+1.17+2.33%
Data as of 1:41pm ET, 12/13/2017

Financials

Next reporting dateFebruary 8, 2018
EPS forecast (this quarter)$0.01
Annual revenue (last year)$15.0M
Annual profit (last year)-$141.1M
Net profit margin-940.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Kevin Charles Gorman
Chief Financial Officer
Matthew C. Abernethy
Corporate headquarters
San Diego, California

Forecasts